DV
Therapeutic Areas
AtaCor Medical Pipeline
| Drug | Indication | Phase |
|---|---|---|
| AtaCor EV-ICD Lead System | Prevention of Sudden Cardiac Death (Ventricular Fibrillation/Tachycardia) | Feasibility / Early Clinical |
Leadership Team at AtaCor Medical
RS
Rick Sanghera
President & Chief Executive Officer
SM
Sean McGeehan
General Counsel & Chief Financial Officer
DM
Dr. Martin Burke
Chief Medical Officer
AM
Alan Marcovecchio
Vice President of Regulatory and Quality
JH
Jon Hunt
Vice President of Clinical Affairs
MR
Matthew Rollins
Vice President of Product Development
DG
Dr. Gary Gershony
Scientific Advisory Board
DR
Dr. Reinoud Knops
Scientific Advisory Board
DS
Dr. Shephal Doshi
Scientific Advisory Board
JT
Jeff Terrell
Board Member, Partner at Arboretum Ventures